Description

Product information

IUPAC-name      1-(2,3-Dihydro-1-benzofuran-5-yl)propan-2-amine

Synonyms  5-APDB, 3-Desoxy-MDA, EMA-4, 5-(2-Aminopropyl)-2,3-dihydrobenzofuran, 3-desoxy-MDA

Formal name  2,3-dihydro-α-methyl-5-benzofuranethanamine, monohydrochloride

Cas number    152624-03-8, 152623-94-4 HCI

Formula  C₁₁H₁₅NO, C₁₁H₁₅NO • HCl

Molar Mass   177.247 g·mol⁻¹

Purity  98.0 % min.

Formulation    Powder, Solid, Crystals

5-APDB, 3-Desoxy-MDA, EMA-4, 5-(2-Aminopropyl)-2,3-dihydrobenzofuran, 3-desoxy-MDA

5-(2-Aminopropyl)-2,3-dihydrobenzofuran is a potential entactogen of amphetamine and phenethylamine classes. It is an analogue of the former that has been used in the treatment of various diseases. The latter, 6-APDB, is an analogue of the former that has been used in the research of non-neurotoxic MDMA analogues.

It can block the reuptake of certain neurotransmitters such as serotonin and dopamine by replacing the 3,4methylenedioxy ring with a methylene group. In drug discrimination studies, 5-APDB exhibits similar effects to those of other non-stimulant agents such as MDMA and MBDB.

In vitro studies show that 5-Aminopropyl-5-APDB’s effects are most similar to those of non-stimulant agents such as MMAI and MBDB. It also acts as a selective serotonin releasing agent, which can prevent the reuptake of certain neurotransmitters such as serotonin and dopamine. On the other hand, 6-APDB acts more like MDMA and is more balanced on its three monoamine receptors.

In animal tests, the two analogues of 5-APDB and 6-APDB were substituted for DOM. Although these were less potent than DOM, they were still able to show the same effects.

The toxicological and physiological properties of this compound has not been analyzed. Usage of this Chemical should be for research and forensic purposes only.

WARNING This product is not for human or veterinary use.

This product is only available to persons of 21 years old and above.

Hazard statement(s)